COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,646 Articles (22,913 medRxiv, 8,733 bioRxiv)

Most recent first Previous |  Page 2330: Articles 23291-23300  | Next

Dark matter, second waves and epidemiological modelling
Friston, K., Costello, A., Pillay, D.
10.1101/2020.09.01.20185876 — Posted: 2020-09-03 Discussion: Onsite
Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?
Sieiro Santos, C., Casas Fernandez, X., Moriano Morales, C., Alvarez Diez, E., Alvarez Castro, C., Lopez Robles, A., Perez Sandoval, T.
10.1101/2020.09.01.20184333 — Posted: 2020-09-03
Face-masking, an acceptable protective measure against COVID-19: Findings of Ugandan high-risk groups
Aruhomukama, D., Mboowa, G., Musoke, D., Bulafu, D.
10.1101/2020.08.29.20184325 — Posted: 2020-09-03
Prognostic accuracy of emergency department triage tools for children with suspected COVID-19: The PRIEST observational cohort study
Biggs, K., Thomas, B., Goodacre, S., Lee, E., Sutton, L., Loban, A., Waterhouse, S., Simmonds, R., Marincowitz, C., Schutter, J., Connelly, S., Sheldon, E., Hall, J., Young, E., Bentley, A., Challen, K., Fitzsimmons, C., Harris, T., Lecky, F., Lee, A., Maconochie, I., Walter, D.
10.1101/2020.09.01.20185793 — Posted: 2020-09-03
Optimizing direct RT-LAMP to detect transmissible SARS-CoV-2 from primary patient samples
Dudley, D. M., Newman, C. M., Weiler, A. M., Ramuta, M. D., Shortreed, C. G., Heffron, A. S., Accola, M. A., Rehrauer, W. M., Friedrich, T., O'Connor, D. H.
10.1101/2020.08.30.20184796 — Posted: 2020-09-02
Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19
Reyes, M., Filbin, M. R., Bhattacharyya, R. P., Sonny, A., Mehta, A., Billman, K., Kays, K. R., Pinilla-Vera, M., Benson, M. E., MGH COVID-19 Collection & Processing Team, , Cosimi, L. A., Hung, D. T., Levy, B. D., Villani, A.-C., Sade-Feldman, M., Baron, R. M., Goldberg, M. B., Blainey, P. C., Hacohen, N.
10.1101/2020.09.02.280180 — Posted: 2020-09-02
Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the Hologic Panther Fusion
Cordes, A. K., Rehrauer, W. M., Accola, M. M., Woelk, B., Hilfrich, B., Heim, A.
10.1101/2020.08.31.20185074 — Posted: 2020-09-02
Deep-learning convolutional neural networks with transfer learning accurately classify COVID19 lung infection on portable chest radiographs
Kikkisetti, S., Zhu, J., Shen, B., Li, H., Duong, T.
10.1101/2020.09.02.20186759 — Posted: 2020-09-02
Modeling SARS-CoV-2 infection in vitro with a human intestine-on-chip device
Guo, Y., Luo, R., Wang, Y., Deng, P., Zhang, M., Wang, P., Zhang, X., Cui, K., Tao, T., Li, Z., Chen, W., Zheng, Y., Qin, J.
10.1101/2020.09.01.277780 — Posted: 2020-09-02
Structural Variants in SARS-CoV-2 Occur at Template-Switching Hotspots
Chrisman, B., Paskov, K., Stockham, N., Tabatabaei, K., Jung, J.-Y., Washington, P., Varma, M., Woo Sun, M., Maleki, S., Wall, D. P.
10.1101/2020.09.01.278952 — Posted: 2020-09-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).